by clearskymd | Jun 4, 2018 | Company News
ClearSky Medical Diagnostics is delighted to announce the appointment of two new members of staff – Marta Vallejo and Amir Dehsarvi. Dr Vallejo has joined ClearSky in the newly-formed role of Head of AI and Machine Learning and will be responsible for the development...
by clearskymd | Jun 1, 2018 | Company News
Implementing ClearSky’s LID-Monitor in UK hospitals ‘has the potential to reduce costs to the NHS and increase the quality of life of people with Parkinson’s’… Parkinson’s is a progressive neurological condition – the second most common neurodegenerative disorder...
by clearskymd | May 31, 2018 | Blog
Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine. People with Parkinson’s lack enough dopamine because some of the brain cells that make it have died. The loss of...
by clearskymd | Apr 1, 2018 | Company News
The ClearSky China team exhibited at the 2018 Shanghai Ruijin International Forum of Translational Research in Neurodegenerative Disease in March. It was also the second annual meeting of neurodegenerative diseases of The Chinese Neuroscience Society. Around 300...
by clearskymd | Mar 4, 2018 | Blog
ClearSky Medical Diagnostics’ portfolio of non-invasive devices for diagnosing and monitoring neurodegenerative conditions is based on unique biologically-inspired technology. We use a range of standard peripherals, including tablets, sensors, and data gloves, to...
by clearskymd | Feb 24, 2018 | Blog
Complex figure tests are widely used neuropsychological tests where participants are asked to reproduce a complicated line drawing, first by copying it freehand and then drawing it from memory. One such ‘pen and paper’ test is the Rey Osterrieth Figure (ROCF), which...
by clearskymd | Oct 17, 2017 | Company News
Ruijin Hospital in Shanghai has launched the world’s largest single centre clinical validation study for diagnosing Parkinson’s. The first phase of the research study, which will be completed by the end of 2017, involves 200 patients with Parkinson’s and...
by clearskymd | Sep 29, 2017 | Company News
Dr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October. The conference provides people affected by Parkinson’s the ideal opportunity to learn more about the work supported by...
by clearskymd | Sep 20, 2017 | Company News
ClearSky Medical Diagnostics is looking forward to attending and exhibiting at MEDICA 2017, the international medical trade fair. MEDICA is the world’s largest event for the medical sector – more than 128,000 international trade visitors from 70 countries attended the...
by clearskymd | Aug 25, 2017 | Blog
Dr Keith Morris has been appointed the Quality Assurance and Regulatory Affairs Counsel for ClearSky Medical Diagnostics. Keith has more than 20 years’ experience in the pharmaceutical, healthcare and medical industries and huge experience of regulatory and quality...
Recent Comments